Works matching DE "RIFAMPIN"

Results: 3688

Solution reduces infection risk in penile prosthesis.

Published in:

Urology Times, 2011, v. 39, n. 3, p. 20

By:

Overmyer, Mac

Publication type:

Article

Completion of isoniazid-rifapentine (3HP) for tuberculosis prevention among people living with HIV: Interim analysis of a hybrid type 3 effectiveness-implementation randomized trial.

Published in:

2021

By:

Semitala, Fred C.;
Kadota, Jillian L.;
Musinguzi, Allan;
Nabunje, Juliet;
Welishe, Fred;
Nakitende, Anne;
Akello, Lydia;
Bishop, Opira;
Patel, Devika;
Sammann, Amanda;
Nahid, Payam;
Belknap, Robert;
Kamya, Moses R.;
Handley, Margaret A.;
Phillips, Patrick P. J.;
Katahoire, Anne;
Berger, Christopher A.;
Kiwanuka, Noah;
Katamba, Achilles;
Dowdy, David W.

Publication type:

journal article

Add or switch to systemics and biologics where topical paediatric hidradenitis suppurativa therapy fails.

Published in:

Drugs & Therapy Perspectives, 2024, v. 40, n. 6, p. 211, doi. 10.1007/s40267-024-01076-7

By:

Fenton, Caroline;
Kang, Connie

Publication type:

Article

Ocular surface leproma.

Published in:

2018

By:

Ram, J.;
Kakkar, N.;
Gupta, G.;
Gupta, P. C.

Publication type:

Case Study

Current status of multidrug resistant tuberculosis in a tertiary care hospital of East Delhi.

Published in:

Journal of Postgraduate Medicine, 2013, v. 59, n. 3, p. 173, doi. 10.4103/0022-3859.118031

By:

Sagar, T.;
Singh, N. P.;
Kashyap, B.;
Kaur, I. R.

Publication type:

Article

Resistance pattern in drug-resistant pulmonary tuberculosis.

Published in:

Journal of Postgraduate Medicine, 2011, v. 57, n. 3, p. 181, doi. 10.4103/0022-3859.85197

By:

Nagaraja, C.;
Shashibhushan, B. L.;
Sagar, C.;
Asif, M.;
Manjunath, P. H.

Publication type:

Article

Treatment of leprosy in India.

Published in:

Journal of Postgraduate Medicine, 2009, v. 55, n. 3, p. 220, doi. 10.4103/0022-3859.57410

By:

Gautam, V. P.

Publication type:

Article

Intrahepatic cholestasis of pregnancy – Diagnosis and management: A consensus statement of the Society of Obstetric Medicine of Australia and New Zealand (SOMANZ): Executive summary.

Published in:

Australian & New Zealand Journal of Obstetrics & Gynaecology, 2023, v. 63, n. 5, p. 656, doi. 10.1111/ajo.13719

By:

Hague, William M.;
Briley, Annette;
Callaway, Leonie;
Dekker Nitert, Marloes;
Gehlert, Jessica;
Graham, Dorothy;
Grzeskowiak, Luke;
Makris, Angela;
Markus, Corey;
Middleton, Philippa;
Peek, Michael J.;
Shand, Antonia;
Stark, Michael;
Waugh, Jason

Publication type:

Article

Bacterial Outer Membrane‐Coated Mesoporous Silica Nanoparticles for Targeted Delivery of Antibiotic Rifampicin against Gram‐Negative Bacterial Infection In Vivo.

Published in:

Advanced Functional Materials, 2021, v. 31, n. 35, p. 1, doi. 10.1002/adfm.202103442

By:

Wu, Shuang;
Huang, Yi;
Yan, Jiachang;
Li, Yuzhen;
Wang, Jinfeng;
Yang, Yi Yan;
Yuan, Peiyan;
Ding, Xin

Publication type:

Article

Tuning the porosity of hypercrosslinked styrene-divinylbenzene copolymers for efficient adsorption of rifampicin from aqueous media.

Published in:

Journal of Polymer Research, 2023, v. 30, n. 11, p. 1, doi. 10.1007/s10965-023-03802-7

By:

Kirillov, Anton S.;
Gorshkov, Nikolay I.;
Shevchenko, Natalia N.;
Saprykina, Natalia N.;
Krasikov, Valeriy D.

Publication type:

Article

Potential interactions between irinotecan and rifampin in a patient with small-cell lung cancer.

Published in:

International Journal of Clinical Oncology, 2004, v. 9, n. 3, p. 206, doi. 10.1007/s10147-004-0394-4

By:

Kan Yonemori;
Yuichiro Takeda;
Emiko Toyota;
Nobuyuki Kobayashi;
Koichiro Kudo

Publication type:

Article

Management of rifamycins-everolimus drug-drug interactions in a liver-transplant patient with pulmonary tuberculosis.

Published in:

Transplant International, 2012, v. 25, n. 11, p. e120, doi. 10.1111/j.1432-2277.2012.01561.x

By:

Lefeuvre, Sandrine;
Rebaudet, Stanislas;
Billaud, Eliane M.;
Wyplosz, Benjamin

Publication type:

Article

The tale of microencapsulated rifampicin: is it useful for the treatment of periprosthetic joint infection?

Published in:

2022

By:

López-Torres, Irene Isabel;
Vaquero-Martín, Javier;
Torres-Suárez, Ana-Isabel;
Navarro-García, Federico;
Fraguas-Sánchez, Ana-Isabel;
León-Román, Víctor Estuardo;
Sanz-Ruíz, Pablo

Publication type:

journal article

Factors affecting outcome in the treatment of streptococcal periprosthetic joint infections: results from a single-centre retrospective cohort study.

Published in:

International Orthopaedics, 2021, v. 45, n. 1, p. 57, doi. 10.1007/s00264-020-04722-7

By:

Andronic, Octavian;
Achermann, Yvonne;
Jentzsch, Thorsten;
Bearth, Flurin;
Schweizer, Andreas;
Wieser, Karl;
Fucentese, Sandro F.;
Rahm, Stefan;
Zinkernagel, Annelies S.;
Zingg, Patrick O.

Publication type:

Article

Predictors of treatment outcome in prosthetic joint infections treated with prosthesis retention.

Published in:

International Orthopaedics, 2015, v. 39, n. 9, p. 1785, doi. 10.1007/s00264-015-2819-2

By:

Puhto, Ari-Pekka;
Puhto, Teija;
Niinimäki, Tuukka;
Ohtonen, Pasi;
Leppilahti, Juhana;
Syrjälä, Hannu

Publication type:

Article

Pharmacokinetics-pharmacodynamics of first-line antitubercular drugs: a comparative study in tuberculosis patients with and without concomitant diabetes mellitus.

Published in:

European Journal of Clinical Pharmacology, 2024, v. 80, n. 12, p. 1945, doi. 10.1007/s00228-024-03754-x

By:

Mondal, Sourav;
Roy, Vandana;
Meshram, Girish Gulab;
Khanna, Ashwani;
Velpandian, Thirumurthy;
Garg, Sandeep

Publication type:

Article

Assessment of body mass-related covariates for rifampicin pharmacokinetics in healthy Caucasian volunteers.

Published in:

European Journal of Clinical Pharmacology, 2024, v. 80, n. 9, p. 1271, doi. 10.1007/s00228-024-03697-3

By:

Bilal, Muhammad;
Ullah, Sami;
Jaehde, Ulrich;
Trueck, Christina;
Zaremba, Dario;
Wachall, Bertil;
Wargenau, Manfred;
Scheidel, Bernhard;
Wiesen, Martin H. J.;
Gazzaz, Malaz;
Chen, Chunli;
Büsker, Sören;
Fuhr, Uwe;
Taubert, Max;
Dokos, Charalambos

Publication type:

Article

The effects of drug-drug interaction on linezolid pharmacokinetics: A systematic review.

Published in:

European Journal of Clinical Pharmacology, 2024, v. 80, n. 6, p. 785, doi. 10.1007/s00228-024-03652-2

By:

Xu, Qiang;
Sang, Yanlei;
Gao, Anna;
Li, Lu

Publication type:

Article

Evaluation of CYP2C19 activity using microdosed oral omeprazole in humans.

Published in:

European Journal of Clinical Pharmacology, 2022, v. 78, n. 6, p. 975, doi. 10.1007/s00228-022-03304-3

By:

Elbe, Annika;
Foerster, Kathrin Isabelle;
Blank, Antje;
Rose, Peter;
Burhenne, Jürgen;
Haefeli, Walter Emil;
Mikus, Gerd

Publication type:

Article

Physiologically based pharmacokinetic modelling to predict the clinical effect of CYP3A inhibitors/inducers on esaxerenone pharmacokinetics in healthy subjects and subjects with hepatic impairment.

Published in:

European Journal of Clinical Pharmacology, 2022, v. 78, n. 1, p. 65, doi. 10.1007/s00228-021-03194-x

By:

Watanabe, Akiko;
Ishizuka, Tomoko;
Yamada, Makiko;
Igawa, Yoshiyuki;
Shimizu, Takako;
Ishizuka, Hitoshi

Publication type:

Article

A case series of the rifampin-warfarin drug interaction: focus on practical warfarin management.

Published in:

European Journal of Clinical Pharmacology, 2021, v. 77, n. 3, p. 341, doi. 10.1007/s00228-020-03057-x

By:

Yang, Charlotte S.;
Boswell, Rosaleen;
Bungard, Tammy J.

Publication type:

Article

Evaluation of iberdomide and cytochrome p450 drug-drug interaction potential in vitro and in a phase 1 study in healthy subjects.

Published in:

European Journal of Clinical Pharmacology, 2021, v. 77, n. 2, p. 223, doi. 10.1007/s00228-020-03004-w

By:

Gaudy, Allison;
Atsriku, Christian;
Ye, Ying;
MacGorman, Kimberly;
Liu, Liangang;
Xue, Yongjun;
Surapaneni, Sekhar;
Palmisano, Maria

Publication type:

Article

Identification of the caffeine to trimethyluric acid ratio as a dietary biomarker to characterise variability in cytochrome P450 3A activity.

Published in:

European Journal of Clinical Pharmacology, 2019, v. 75, n. 9, p. 1211, doi. 10.1007/s00228-019-02682-5

By:

van Dyk, Madelé;
Miners, John O.;
Marshall, Jean-Claude;
Wood, Linda S.;
Hopkins, Ashley;
Sorich, Michael J.;
Rowland, Andrew

Publication type:

Article

Siponimod pharmacokinetics, safety, and tolerability in combination with rifampin, a CYP2C9/3A4 inducer, in healthy subjects.

Published in:

European Journal of Clinical Pharmacology, 2018, v. 74, n. 12, p. 1593, doi. 10.1007/s00228-018-2533-2

By:

Gardin, Anne;
Gray, Cathy;
Neelakantham, Srikanth;
Huth, Felix;
Davidson, Antonia M.;
Dumitras, Swati;
Legangneux, Eric;
Shakeri-Nejad, Kasra

Publication type:

Article

Neuropsychiatric manifestations among HIV-1 infected African patients receiving efavirenz-based cART with or without tuberculosis treatment containing rifampicin.

Published in:

European Journal of Clinical Pharmacology, 2018, v. 74, n. 11, p. 1405, doi. 10.1007/s00228-018-2499-0

By:

Mugusi, Sabina;
Ngaimisi, Eliford;
Janabi, Mohammed;
Mugusi, Ferdinand;
Minzi, Omary;
Aris, Eric;
Bakari, Muhammad;
Bertilsson, Leif;
Burhenne, Juergen;
Sandstrom, Eric;
Aklillu, Eleni

Publication type:

Article

Assessment of inter-racial variability in CYP3A4 activity and inducibility among healthy adult males of Caucasian and South Asian ancestries.

Published in:

European Journal of Clinical Pharmacology, 2018, v. 74, n. 7, p. 913, doi. 10.1007/s00228-018-2450-4

By:

van Dyk, Madelé;
Marshall, Jean-Claude;
Sorich, Michael J;
Wood, Linda S.;
Rowland, Andrew

Publication type:

Article

Effects of cytochrome P450 (CYP3A4 and CYP2C19) inhibition and induction on the exposure of selumetinib, a MEK1/2 inhibitor, in healthy subjects: results from two clinical trials.

Published in:

European Journal of Clinical Pharmacology, 2017, v. 73, n. 2, p. 175, doi. 10.1007/s00228-016-2153-7

By:

Dymond, Angela;
Martin, Paul;
So, Karen;
Mariani, Gabriella;
Huang, Yifan;
Severin, Paul;
Mathews, David;
Lisbon, Eleanor

Publication type:

Article

Concomitant administration of rifampicin and oxcarbazepine results in a significant decrease of the active MHD metabolite of oxcarbazepine.

Published in:

2016

By:

Sigaroudi, Ali;
Kullak-Ublick, Gerd;
Weiler, Stefan

Publication type:

Letter

Effective CSF concentrations achieved with continuous-infusion flucloxacillin in a child.

Published in:

2015

By:

Boast, Alison;
Carr, Jeremy;
Curtis, Nigel;
Daley, Andrew;
Gwee, Amanda

Publication type:

Letter

The effects of ketoconazole and rifampin on the single-dose pharmacokinetics of crizotinib in healthy subjects.

Published in:

European Journal of Clinical Pharmacology, 2015, v. 71, n. 12, p. 1441, doi. 10.1007/s00228-015-1945-5

By:

Xu, Huiping;
O'Gorman, Melissa;
Tan, Weiwei;
Brega, Nicoletta;
Bello, Akintunde

Publication type:

Article

Prolonged inductive effect of rifampicin on linezolid exposure.

Published in:

2015

By:

Gervasoni, Cristina;
Simonetti, Francesco;
Resnati, Chiara;
Charbe, Nitin;
Clementi, Emilio;
Cattaneo, Dario

Publication type:

Letter

A pharmacometric pulmonary model predicting the extent and rate of distribution from plasma to epithelial lining fluid and alveolar cells-using rifampicin as an example.

Published in:

European Journal of Clinical Pharmacology, 2015, v. 71, n. 3, p. 313, doi. 10.1007/s00228-014-1798-3

By:

Clewe, Oskar;
Goutelle, Sylvain;
Conte, John;
Simonsson, Ulrika

Publication type:

Article

Comparison of two endogenous biomarkers of CYP3A4 activity in a drug-drug interaction study between midostaurin and rifampicin.

Published in:

European Journal of Clinical Pharmacology, 2014, v. 70, n. 8, p. 915, doi. 10.1007/s00228-014-1675-0

By:

Dutreix, Catherine;
Lorenzo, Sebastien;
Wang, Yanfeng

Publication type:

Article

Effect of a single-dose rifampin on the pharmacokinetics of pitavastatin in healthy volunteers.

Published in:

European Journal of Clinical Pharmacology, 2013, v. 69, n. 11, p. 1933, doi. 10.1007/s00228-013-1554-0

By:

Chen, Yao;
Zhang, Wei;
Huang, Wei-hua;
Tan, Zhi-rong;
Wang, Yi-cheng;
Huang, Xi;
Zhou, Hong-Hao

Publication type:

Article

Rifampicin markedly decreases the exposure to oral and intravenous tramadol.

Published in:

European Journal of Clinical Pharmacology, 2013, v. 69, n. 6, p. 1293, doi. 10.1007/s00228-012-1460-x

By:

Saarikoski, Tuukka;
Saari, Teijo;
Hagelberg, Nora;
Neuvonen, Mikko;
Neuvonen, Pertti;
Scheinin, Mika;
Olkkola, Klaus;
Laine, Kari

Publication type:

Article

Effect of rifampicin on the pharmacokinetics and pharmacodynamics of ticagrelor in healthy subjects.

Published in:

European Journal of Clinical Pharmacology, 2013, v. 69, n. 4, p. 877, doi. 10.1007/s00228-012-1436-x

By:

Teng, Renli;
Mitchell, Patrick;
Butler, Kathleen

Publication type:

Article

The influence of tuberculosis treatment on efavirenz clearance in patients co-infected with HIV and tuberculosis.

Published in:

European Journal of Clinical Pharmacology, 2012, v. 68, n. 5, p. 689, doi. 10.1007/s00228-011-1166-5

By:

Gengiah, Tanuja;
Holford, Nicholas;
Botha, Julia;
Gray, Andrew;
Naidoo, Kogieleum;
Abdool Karim, Salim

Publication type:

Article

Interaction of flucloxacillin and quinidine.

Published in:

2012

By:

Comuth, W.;
Comuth, J.;
Hauer, R.;
Malingré, M.

Publication type:

Letter

Population pharmacokinetics of lopinavir in combination with rifampicin-based antitubercular treatment in HIV-infected South African children.

Published in:

European Journal of Clinical Pharmacology, 2010, v. 66, n. 10, p. 1017, doi. 10.1007/s00228-010-0847-9

By:

Elsherbiny, Doaa;
Ren, Yuan;
McIlleron, Helen;
Maartens, Gary;
Simonsson, Ulrika

Publication type:

Article

Rifampicin reduces the plasma concentrations and the renin-inhibiting effect of aliskiren.

Published in:

European Journal of Clinical Pharmacology, 2010, v. 66, n. 5, p. 497, doi. 10.1007/s00228-010-0796-3

By:

Tapaninen, Tuija;
Neuvonen, Pertti;
Niemi, Mikko

Publication type:

Article

Evaluation of drug–drug interactions with fesoterodine.

Published in:

European Journal of Clinical Pharmacology, 2009, v. 65, n. 6, p. 551, doi. 10.1007/s00228-009-0648-1

By:

Malhotra, Bimal;
Sachse, Richard;
Wood, Nolan

Publication type:

Article

Population pharmacokinetics of nevirapine in combination with rifampicin-based short course chemotherapy in HIV- and tuberculosis-infected South African patients.

Published in:

European Journal of Clinical Pharmacology, 2009, v. 65, n. 1, p. 71, doi. 10.1007/s00228-008-0481-y

By:

Elsherbiny, Doaa;
Cohen, Karen;
Jansson, Britt;
Smith, Peter;
McIlleron, Helen;
Simonsson, Ulrika S. H.

Publication type:

Article

Rifampicin is only a weak inducer of CYP1A2-mediated presystemic and systemic metabolism: studies with tizanidine and caffeine.

Published in:

European Journal of Clinical Pharmacology, 2006, v. 62, n. 6, p. 451, doi. 10.1007/s00228-006-0127-x

By:

Backman, Janne T.;
Granfors, Marika T.;
Neuvonen, Pertti J.

Publication type:

Article

Cytochrome P<sub>450</sub> mRNA expression in peripheral blood lymphocytes as a predictor of enzyme induction.

Published in:

European Journal of Clinical Pharmacology, 2005, v. 61, n. 8, p. 583, doi. 10.1007/s00228-005-0971-0

By:

Haas, Curtis E.;
Brazeau, Daniel;
Cloen, Denise;
Booker, Brent M.;
Frerichs, Valerie;
Zaranek, Colleen;
Frye, Reginald F.;
Kufel, Thomas

Publication type:

Article

Oral administration of a low dose of midazolam (75 μg) as an in vivo probe for CYP3A activity.

Published in:

European Journal of Clinical Pharmacology, 2004, v. 60, n. 4, p. 237, doi. 10.1007/s00228-004-0762-z

By:

Eap, Chin B.;
Buclin, Thierry;
Cucchia, Gianni;
Zullino, Daniele;
Hustert, Elisabeth;
Bleiber, Gabriela;
Golay, Kerry Powell;
Aubert, Anne-Catherine;
Baumann, Pierre;
Telenti, Amalio;
Kerb, Reinhold

Publication type:

Article

Rifampicin seems to act as both an inducer and an inhibitor of the metabolism of repaglinide.

Published in:

European Journal of Clinical Pharmacology, 2004, v. 60, n. 2, p. 109, doi. 10.1007/s00228-004-0746-z

By:

Bidstrup, Tanja Busk;
Stilling, Nicolaj;
Damkier, Per;
Scharling, Birgitte;
Thomsen, Mikael Sônderg&arinf;rd;
Brôsen, Kim

Publication type:

Article

Rifampicin reduces plasma concentrations of celiprolol.

Published in:

European Journal of Clinical Pharmacology, 2004, v. 59, n. 11, p. 819, doi. 10.1007/s00228-003-0694-z

By:

Lilja, J. J.;
Niemi, M.;
Neuvonen, P. J.

Publication type:

Article

The Microbiological and Clinical Effects of Combined Therapy according to Guidelines on the Treatment of Pulmonary Mycobacterium avium Complex Disease in Japan – Including a Follow-Up Study.

Published in:

Respiration, 2007, v. 74, n. 4, p. 394, doi. 10.1159/000095674

By:

Kobashi, Yoshihiro;
Matsushima, Toshiharu

Publication type:

Article

Acute Respiratory Distress Syndrome Induced by Rifampicin with High Levels of Neutrophil and Eosinophil Products in Bronchoalveolar Lavage Fluid.

Published in:

Respiration, 2003, v. 70, n. 5, p. 541, doi. 10.1159/000074216

By:

Ashitani, Jun-ichi;
Yanagi, Shigehisa;
Arimura, Yasuji;
Sano, Arisa;
Mukae, Hiroshi

Publication type:

Article

Interception of host angiogenic signalling limits mycobacterial growth.

Published in:

Nature, 2015, v. 517, n. 7536, p. 612, doi. 10.1038/nature13967

By:

Oehlers, Stefan H.;
Cronan, Mark R.;
Scott, Ninecia R.;
Thomas, Monica I.;
Okuda, Kazuhide S.;
Walton, Eric M.;
Beerman, Rebecca W.;
Crosier, Philip S.;
Tobin, David M.

Publication type:

Article